Summary by Moomoo AI
CHINA BIOPHARMACEUTICAL CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 5, 2024. THE MEETING WILL BE HELD IN A HYBRID MODE OF PHYSICAL MEETINGS COMBINED WITH ONLINE VIRTUAL MEETINGS. THE MAIN AGENDA OF THE MEETING INCLUDES THE REVIEW AND ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023, THE BOARD'S REPORT AND THE INDEPENDENT AUDITOR'S REPORT, THE APPROVAL OF THE DISTRIBUTION OF THE FINAL DIVIDEND, AND THE RE-ELECTION OF MR. XIE PING, MR. LU ZHENFEI AND MR. LI TAI QUAI AS DIRECTORS. In addition, the meeting will authorize the Board of Directors to determine the remuneration of directors, to renew and determine the remuneration of EY Accountants as auditor for the next financial year...Show More